Impact of DOTS compared with DOTS-plus on multidrug resistant tuberculosis and tuberculosis deaths: decision analysis
about
Cost-effectiveness of treating multidrug-resistant tuberculosisFactors related to adopting healthy behaviors by patients with tuberculosis in Isfahan: Application of health belief model.Prevention of nosocomial transmission of extensively drug-resistant tuberculosis in rural South African district hospitals: an epidemiological modelling study.Management of multidrug-resistant tuberculosis: Update 2007.A First Insight into the Genetic Diversity and Drug Susceptibility Pattern of Mycobacterium tuberculosis Complex in Zhejiang, China.Management of multidrug-resistant tuberculosis: an update.Mathematical models of the epidemiology and control of drug-resistant TB.Treatment of multidrug-resistant and extensively drug-resistant tuberculosis: current status and future prospects.Strategies for halting the rise of multidrug resistant TB epidemics: assessing the effect of early case detection and isolation.Impact of DOTS and DOTS-plus on multidrug resistant TB: DOTS-plus strengthens, not weakens, DOTS programmes.Modeling the emergence of the 'hot zones': tuberculosis and the amplification dynamics of drug resistance.Common errors in multidrug-resistant tuberculosis management.MDR-/XDR-TB management: what it was, current standards and what is ahead.Genomic Epidemiology of Tuberculosis.Multidrug-resistant tuberculosis treatment adherence in migrants: a systematic review and meta-analysis.
P2860
Q28469015-7B499501-77D7-4D02-8E0D-2871F9E67FC4Q34186630-110452C9-C4F3-4353-87AA-52482BDBCAE5Q34707237-55BECA69-5291-42FD-A9FB-409F3AC413A0Q37058166-035FC4B2-5CE4-4D9B-A96A-78EF6D7F4BBEQ37475592-6CDF2E9F-6A0A-46A3-A4D0-C1F2C692E3D0Q37730293-38A026CB-DC7D-4EB0-AF7B-9A481F84E63CQ37754966-594D035D-D19F-4E4D-AFB0-972D0683A4E0Q39967041-02814C8C-3983-42EC-B03E-1DD2A348E130Q40275920-5FBA00F3-4689-4876-A5CE-964141EAD836Q42784477-98AC2FA9-FFE2-48CC-9461-74E71994FC89Q46221499-E55FA4DE-640E-40FD-8C22-13F954BA07FFQ46241770-ADA7DBCB-B318-4229-9701-4342C5F36F88Q46273107-AB84F441-B0F7-4E50-AA68-4C83028145C0Q50107990-D201B668-EA5F-4555-891F-6B24BAA23C31Q50299758-AE82DAAF-6192-457C-AC5D-6039D1D6F111
P2860
Impact of DOTS compared with DOTS-plus on multidrug resistant tuberculosis and tuberculosis deaths: decision analysis
description
2003 nî lūn-bûn
@nan
2003 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի մարտին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Impact of DOTS compared with D ...... osis deaths: decision analysis
@ast
Impact of DOTS compared with D ...... osis deaths: decision analysis
@en
Impact of DOTS compared with D ...... osis deaths: decision analysis
@nl
type
label
Impact of DOTS compared with D ...... osis deaths: decision analysis
@ast
Impact of DOTS compared with D ...... osis deaths: decision analysis
@en
Impact of DOTS compared with D ...... osis deaths: decision analysis
@nl
prefLabel
Impact of DOTS compared with D ...... osis deaths: decision analysis
@ast
Impact of DOTS compared with D ...... osis deaths: decision analysis
@en
Impact of DOTS compared with D ...... osis deaths: decision analysis
@nl
P2860
P356
P1433
P1476
Impact of DOTS compared with D ...... osis deaths: decision analysis
@en
P2093
Harold P Lehmann
Timothy R Sterling
P2860
P356
10.1136/BMJ.326.7389.574
P407
P50
P577
2003-03-15T00:00:00Z